Article
Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma.
The Lancet. Respiratory medicine - 1 Jul 2016
Trivedi Abhaya, Pavord Ian D, Castro Mario
Abstract excerpt
Although a small proportion of patients with asthma have severe disease, it accounts for the majority of morbidity related to the illness. Severe asthma comprises a heterogeneous group of phenotypes. Targeted treatments for these phenotypes represent a major advancement in the management of severe asthma. Omalizumab, a monoclonal antibody to IgE, improves asthma control in patients with a predominant allergic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.